CBI's 4th Annual Forum on Clinical Trial Management Systems (CTMS)


Published on

Brochure from CBI's 4th Annual Forum on Clinical Trial Management Systems (CTMS). BioPharm Systems held a workshop on how to build an effective CTMS training program at the event.

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

CBI's 4th Annual Forum on Clinical Trial Management Systems (CTMS)

  1. 1. R e g i s t e r b y J a n u a r y 2 1 , 2 0 1 1 a n d R e c e i v e $ 3 0 0 O f f o f Yo u r R e g i s t r a t i o n F e e ! CBi’s 4th annual forum on Clinical Trial Management Systems (CTMS) Adoption, Integration and Management Solutions to Maximize the Value of Investments March 24-25, 2011 • crowne Plaza • PhiladelPhia, Pa Balanced perspectives ConferenCe Chairperson: Leverage CTMS to enable strategic regarding various types of CTMS Karen Travers, Director, Product Strategy, clinical operational efficiencies systems Oracle Health Sciences Analyze criteria used to make a CTMS selection fDa aDDress: “Understand Potential Regulatory Learn the benefits and challenges of co-developing a Issues and Inspection Expectations” Jonathan S. Helfgott, Consumer Safety Officer, CTMS with a CRO versus purchasing an application CDRH’s Division of Bioresearch Monitoring, Food and Drug Administration Understand resource requirements for data migration resulting from a merger of two separate systems national CanCer institute aDDress Manage shared CTMS data between sponsor and CRO “NCI Update on the (caBIG ) Initiative” ® David Loose, Contractor, NCI Center for Biomedical Adapt CTMS to incorporate payment structure shifts Informatics and Information Technology (CBIIT) Bill Dyer, Contractor, NCI Center for Biomedical Lower Total Cost of Ownership (TCO) through Informatics and Information Technology (CBIIT) CTMS simplification aCaDemiC meDiCal Choose Between Two Pre-Conference Workshops — Thursday, March 24, 2011 Center aDDress: “A Site-Based Approach to CTMS” A. Increase ROI B. Build Organizational Anthony Leiro, Manager, Business Architecture, Information Technology, Duke Clinical Research Institute (DCRI) through an Bridges for Cross-Functional Effective CTMS Collaboration and Case stuDies anD Training Program Decision-Making perspeCtives from: BioPharm Systems • DSP Clinical Research Presenting Lead Media Partner: Sponsor: Ferring International PharmaScience Centre Genentech, A Member of the Roche GroupArtwork by: Getty Images GlaxoSmithKline • Merck & Co., Inc. Millennium: The Takeda Oncology Company Organized by: Lead Media Partner: Perceptive Informatics • Quintiles sanofi-aventis • Sanofi Pasteur • Target Health A Subsidiary of For more information, please visit us on the web at www.cbinet.com/ctms
  2. 2. Choose f rom Two Pre-Conference Work shops – Thursday, Ma rch 24, 2011 7:30 Workshop Registration and Continental Breakfast 8:30 • Workshop A 8:30 • Workshop B Build Organizational Bridges Increase ROI through an Effective for Cross-Functional Collaboration and CTMS Training Program Decision-MakingWorkshop Objective: Workshop Objective:User adoption is the key to achieving a rapid ROI for CTMS systems are utilized by many key stakeholders, both internalyour CTMS and the key to user adoption is an effective and external to the organization. There are individuals that maketraining program. Such training programs are based on decisions regarding the system; those that support the system; anda careful analysis of an organization’s culture and the those that use the system. It is important to realize that decisionscharacteristics of its end-users. All training programs regarding CTMS impact all key stakeholders and thereforeshould be multi-faceted, comprehensive and long-term in processes for collaboration are critical. This workshop coversscope. But, depending on the organization, the details of a cross-organization collaboration and decision-making while alsoprogram can be tailored to meet the needs of the end-users focusing on the relationship with CROs, between the business andand the organization as a whole. Effective CTMS training technical teams as well as key end-users.programs leave users feeling well-equipped to begin using Key Questions to Be Addressed:the system and fully supported as they master it. Thisworkshop presents a variety of methods for achieving these • Who should be involved in a cross-functional advisory committee?goals and discusses how to choose from these methods to • What is the impact of CTMS changes on other clinical systems?build a training program that is right for your organization. • How is a stronger relationship between business and technical teams created?Key Questions to Be Addressed: • How is feedback from end-users incorporated into the decision-making process?• How do adults learn? Workshop Outline:• What are the different approaches to software training?• Which approaches make sense in different types I. Ensure Cross-Functional Decision-Making for of organizations? CTMS Systems• How can we best prepare users to start using the system? • Understand business priorities and current • How can we continue to support users over time? decision-making structure • Create a cross-functional key stakeholder advisory Workshop Outline: committee to address questions * level of access granted to CROs and other businessI. Understand How Adults Learn partners that comply with privacy regulations • Motivating them to learn • Make key decisions for CTMS initiatives • Helping them retain what they learn * business process changes impacting initiatives timeline changes • Helping them apply what they learn • Implement a Change Control Board (CCB) II. Analyze Your CTMS User Group * evaluate changes to system itself, both business and technical • Organizational culture * determine impact of CTMS changes on other clinical systems • Number and types of users II. Create Stronger Relationship between Technical • Location of users Operations and Business • Understand change requests from businessIII. Develop Your Training Program/Strategy • Evaluate issues impacting systems • Short-term — Initial rollout • Eliminate technical and business silos • Medium-term — Reference materials and refreshers III. End-User Forums to Provide Consistent Feedback • Long-term — • Grass-roots forum where users can voice concerns, challenges Clear and effective support structure • Discuss best practices • Hear lessons learned to date12:00 Close of Workshop A 12:00 Close of Workshop BThere will be a 30-minute networking and refreshment break at 10:00 a.m. There will be a 30-minute networking and refreshment break at 10:00 a.m.Workshop Leaders: Workshop Leader:Parambir Singh, Vice President, BioPharm Systems, Inc Amy Black, Global Business Program Manager, Shannon L. Beebe, Siebel Coordinator, Covidien Genentech – A Member of the Roche Group
  3. 3. MAIN CONFERENCE National Cancer Institute Address 3:30 NCI Update on the (caBIG®) Initiative Day One — Thursday, March 24, 2011 The cancer Biomedical Informatics Grid (caBIG®) initiative, overseen by the National Institutes of Health’s (NIH), National12:00 Main Conference Registration Cancer Institute (NCI) Center for Biomedical Informatics and1:15 Chairperson’s Opening Remarks Information Technology (CBIIT), was conceived to connect the Karen Travers, Director, Product Strategy, Oracle Health Sciences cancer research and clinical community through a semantically- Ms. Travers has over twenty years experience in Clinical Research working aware service-based, open-source, interoperable technology in both industry and CRO environments. Her experience includes Data that facilitates data sharing and collaboration to accelerate management, Clinical Monitoring, EDC, IVRS and Medical Imaging. the translation of discoveries from research to clinical care. Prior to joining Oracle, she was at Vertex Pharmaceuticals where she led The caBIG® Clinical Trials Management Systems Workspace strategy and implementation of Clinical Development Systems. She was also provides modular caBIG® software tools designed to meet at Perceptive Informatics (a Parexel International Company) where she led diverse clinical trials management needs. caBIG® tools are efforts around IVRS, EDC and Medical Imaging. configurable to work with clinical sites with little or no clinical data management systems in place, as well as those with robust Keynote Address systems; and take into account the diversity of clinical research activities as well as local practices that exist among clinical sites.1:30 Leverage CTMS as a Powerful Decision-Supporting Engine This address discusses the goals and progress of this initiative, Most companies today either have a CTMS or are considering as well as plans for the future. using one to manage the day-to-day activities of their trials. • Hear about the goals of the caBIG® initiative and the As the industry evolves, all the systems used to support clinical NCI vision of interoperability development must evolve as well, including CTMS systems. • Understand challenges and successes to date in This keynote address analyzes the potential evolution of these systems and offers insight into ways to ensure the CTMS enables deployment of the caBIG® Clinical Trials Suite and the decisions critical to supporting future clinical trials. NCI Enterprise Services • Discuss how CTMS can enable the next set of clinical • Learn the next steps with the caBIG® initiative and operational efficiencies the NCI’s plans for restructuring of the NCI Clinical IT Enterprise • Transform CTMS for the future David Loose, Contractor, NCI Center for Biomedical Informatics and Simon Brooks, Product Champion, Integrated Clinical Research Suite, Oracle Health Sciences Information Technology (CBIIT) Bill Dyer, Contractor, NCI Center for Biomedical Informatics and Karen Travers, Director, Product Strategy, Oracle Health Sciences Information Technology (CBIIT) FDA Address Academic Medical Center Address2:15 Understand Potential Regulatory Issues and 4:15 A Site-Based Approach to CTMS Inspection Expectations Clinical sites utilize CTMS systems to record data for clinical CTMS systems can offer operational efficiencies for the trials specific to the study site, not aggregated multi-site study data organization. However, understanding how the data needs to as in most sponsor-led trials. In that way, a disconnect exists in be handled to comply with the FDA as well as what to expect how the information is entered and reported between the clinical during an inspection is critical. This applies to any CTMS site and sponsor. This leads to challenges when sharing data in system. This address discusses the regulatory challenges and study collaborations with sponsors because it requires sites to expectations during an FDA inspection. Attendees are then manage their portfolio of research projects independent of the invited to participate in a Q&A session with the FDA. sponsor. Over the last three years, Duke University has deployed • Potential FDA regulatory issues when using CTMS a site-based CTMS in conducting trials. The CTMS is being systems and its impact on FDA used for over 3,000 different clinical trials and tracking the study * regulated clinical research activities visits of more than 60,000 study participants. The trials that * marketing applications use CTMS range from small single-site research studies to large * inspections multi-site trials. This site-based approach to CTMS provides the site with tools to improve coordination of patient visits, capacity • Hear case examples from the FDA planning, billing integration, resource utilization, financial and • Examine developing trends in clinical systems regulatory compliance as well as managerial reporting. This * merging eClinical systems address discusses the site-based approach to CTMS and the (i.e. EDC/CTMS/CDMS/IVRS) interrelationship with sponsors. * use of EHRs • Hear an overview of Duke’s site-based approach * home healthcare in clinical research to CTMS * clinical data standards • Explore the disconnect between sites and sponsors • Participate in an open discussion with FDA with data from CTMS Jonathan S. Helfgott, Consumer Safety Officer, CDRH’s Division of • Analyze the capabilities of the CTMS and future Bioresearch Monitoring, Food and Drug Administration plans for enhancements Anthony Leiro, Manager, Business Architecture, Information Technology,3:00 Networking and Refreshment Break Duke Clinical Research Institute (DCRI)
  4. 4. Considerations for CTMS Selection and Adoption CTMS System Implementation Strategies5:00 Leverage Interoperability of the CTMS as the 9:00 Leveraging Implementation Experience from eClinical Backbone for All Key Stakeholders Different Business Units for Smoother Transition Managing programs and studies with configurable sanofi-aventis (SA) has been using a CTMS since the mid- off-the-shelf software is a challenge. Those involved in 1990’s. However, Sanofi Pasteur (SP), its vaccine division, has running a trial include the sponsor, contract research only been using a CTMS since 2000. The SA implementation organizations, ethics committees, local and central laboratories and the investigative sites and patients themselves. All of had its challenges. In learning from them, SP has taken a these users have their own needs — their own specific tasks to more cautious roll-out approach and has changed a few of be recorded in, or guided by, ‘their’ software….ePRO, EDC, the processes involved with the implementation. To date, IVR, etc. So, can we even conceive one “master system” to the implementation has gone much smoother and has started coordinate milestones and data? This presentation shows with the capabilities of tracking milestones, written monitor how a CTMS can be considered a ‘backbone’ for the entire visits and developing clinical reporting. Future plans include eClinical framework. Interoperability of a CTMS is interfacing with clinical eDoc and EDC as well as integrating discussed including: with finance. This case study compares and contracts the • User workflow CTMS roll-outs of SA and SP, highlighting specific changes • Dashboards in process that SP adopted as lessons learned. Also to be • Intuitive use of a CTMS discussed are future plans for the CTMS. • Notifications to various users • Examine the CTMS implementations • Tying data together of both SA and SP John Humphreys, CTMS Product Director, Perceptive Informatics • Analyze the changes made to ensure a smoother 5:45 Close of Day One CASE implementation for SP STUDy • Hear future plans for SP CTMS Daniel O’Connell, Manager of Monitoring Systems, Clinical Study Unit, 5:45-6:45 Networking, North America, sanofi-aventis Wine & Cheese Reception William Dubost, Manager of Monitoring Systems, Sanofi Pasteur Join colleagues and friends in a relaxed setting. Parambir Singh, Vice President, BioPharm Systems, Inc.Photo by: Photolink / Getty Images P 9:45 Customization of CTMS in an Outsourced Model Day Two — Friday, March 25, 2011 A This panel discussion offers a look at Millennium’s customization N of CTMS to support their study management needs, including the 7:30 Continental Breakfast development of data migration and data integration components. E As Millennium’s sourcing model changed during the 8:00 Chairperson’s Review of Day One L implementation of the tool, analysis of the impact on the system Karen Travers, Director, Product Strategy, Oracle Health Sciences requirements and business processes are also explored.8:15 Analysis of the Decision Whether to Co-Develop a Moderator: Heather Wolff, Associate Director, Data Operations, CTMS with an eCRO or to Buy an Existing Application Millennium: The Takeda Oncology Company Ferring is a mid-sized pharmaceutical company specializing Panelists: David Roberts, Associate Director, Informatics, in treating diseases mainly through peptide/protein pathways Millennium: The Takeda Oncology Company and initiates about fifteen new phase I-III studies annually. Joe Coady, Lead Clinical Systems Developer, Ferring’s fourteen-year collaboration with Target Health has Millennium: The Takeda Oncology Company resulted in four NDA/MAA and other country approvals. Kevin Lloyd, Director, Clinical Business Operations, In 2008, Target Health had co-developed a CTMS with an Millennium: The Takeda Oncology Company international CRO. The advantages of that collaboration are that there was a deep understanding of clinical research 10:30 Networking and Refreshment Break operations as well the needs of pharmaceutical companies, clinical research sites and regulators. Having outgrown its 11:00 Data Migration through M&A for Global System homemade CTMS, Ferring evaluated several CTMS vendors who would provide and/or build a suitable replacement. Implementation and Deployment This option was attractive because these systems require In 2009 Schering-Plough (SP) and Merck merged to diversify a lot of resources, both to implement and maintain; and its product portfolio and result in a stronger market position. Ferring was not in the software development business. Before the merger, SP and Merck utilized different CTMS The system had to be user-friendly, flexible and easier to systems. A decision had to be made on which system to use interface with their EDC system. This case study analyzes and then data had to be migrated to the chosen system. that decision process, covers progress to date and offers insight This case study covers this process, highlighting key decision into challenges and future plans. points with regards to data migration and roll-out approach as • Maintain flexibility of the system well as discusses challenges faced throughout the process. • Develop a growth plan as the company matures • Understand the resource requirements of the data • Understand the risks involved with co-developing migration and user training a system with a CRO versus an established CASE • Analyze the process of Merck’s roll-out decisionSTUDy CTMS vendor CASE Jules Mitchel, President, Target Health STUDy • Learn future plans for CTMS capabilities Silvana Cappi, MSc., MBA Executive Director, Biometrics, Mark Hill, Executive Director, Clinical Trial Operations, Merck & Co., Inc. Ferring International PharmaScience Centre Chris Heider, Director, IT, Merck & Co., Inc.
  5. 5. “Very important forum to see what the industry is doing.” — 2010 Attendee, Rob Stackhouse, Associate Business Systems Director, R&D Architecture, Shire Pharmaceuticals Effectively Manage CTMS Post-Implementation cost of ownership (TCO) of the system be reduced without compromising data quality, while increasing productivity? 11:45 Analyze the Management of Shared CTMS Data This case study discusses the wider initiative within GSK between Sponsor and CRO regarding its clinical systems and steps taken towards As a function of the outsourcing relationship, sponsors simplification of the CTMS. off-load components of the clinical development process • Overview of the history of GSK’s CTMS to CROs such as patient recruitment and site management, • Hear goals of the corporate-wide initiative regulatory/submission management, etc. Inevitably, as a part of this relationship, decisions regarding where and • Learn the results to date on lowering TCO CASE through simplification how the data is to be managed must be made. When the STUDy data is collected and managed using CRO systems, often Anthony Cavallo, Director, Operational Data Acquisition Support Services, the sponsor needs the data to maintain in-house clinical ISS, CCSE, GlaxoSmithKline development which is not outsourced. This data component can be defined within a broader services contract or in some 3:15 Close of Conference cases a contract is developed to specifically outline these requirements. This case study outlines the export of data to the sponsor to enable a distributed operational partnership. Best practices for managing this process are discussed. In RecognItIon of ouR SponSoRS: • Analyze various types of data export • Design the data model CBI Research, Inc’s corporate sponsors represent select • Ensure data transport protection companies that share a common mission: business advancement • Examine the benefits and pitfalls of this process through thought leadership, strategic interaction and innovation. CASE The companies represented below are proud contributors on thisSTUDy • Discuss where the industry is headed program and have carefully selected messaging, branding or Steven W. Leypoldt, Associate Director, Business Analysis, IT, Quintiles positioning statements to encourage the evaluation and investigation 12:30 Luncheon of quality products and/or services available. We applaud these companies, as well as others that wish to join the conference, 1:45 Customizing a CTMS to Adapt to Changing Needs as important members of this event’s delegation. In 2006, DSP Clinical Research worked with a vendor to create a custom CTMS to meet their needs. Over the past About Our Presenting Sponsor: four years, the CTMS had to be adapted on a continual basis to meet the evolving needs of the organization. Payment structure to sponsors changed from hourly to fixed-rate. DSP implemented internal management processes to retain control of the CTMS to better customize CTMS features. A strategy was developed to ensure excellent customer service from Oracle is a leading strategic software solutions provider the vendor. Although the system works efficiently, there to the health sciences industry. Oracle Health Sciences have been challenges along the way and to date it still has its helps pharmaceutical, biotechnology, medical device and limitations. This case study discusses the process from the healthcare organizations become the most successful in the initial implementation through its adaptations. Challenges, world by offering the most innovative products and services solutions and current limitations are also presented. that deliver the most compelling customer and shareholder • Examine the initial collaboration between DSP and value. Addressing industry requirements, Oracle provides its CTMS vendor comprehensive solutions including clinical trial management • Analyze the adaptations made to the system and analysis, electronic data capture, adverse event reporting CASESTUDy • Discuss benefits, challenges and current limitations and pharmacovigilance and healthcare interoperability. Brenda Reese, Vice President of Business Operations, Oracle partners with health sciences industry leaders to DSP Clinical Research prevent and cure disease and enhance quality of life and accelerate insights for better health. 2:30 Customization versus Simplification — Getting Back to Basics to Lower TCO Over the years, GSK has customized many facets of their Additional Sponsors: CTMS system based on the needs of different therapeutic areas, business areas, etc. Although customizations prove to be useful, they are both expensive to support and can present challenges in upgrading to newer versions. GSK decided to simplify its CTMS, or get back to basics. Can the same processes be supported using core system If you are interested in sponsorship or exhibit opportunities, functionality? What level of customization is necessary please call Alexa Moore at 339-298-2107 or email alexa.moore@cbinet.com versus configuration of the base product? Can the total To Register Call Toll Free 800-817-8601 (339-298-2100 outside the U.S.) or Fax 781-939-2490. Register on our website at www.cbinet.com/ctms
  6. 6. R e g i s t e r b y J a n u a r y 2 1 , 2 0 1 1 a n d R e c e i v e $ 3 0 0 O f f o f Yo u r R e g i s t r a t i o n F e e ! • Utilize CTMS as the sole “master system” CBi’s 4th annual forum on to coordinate milestones and data • Examine implementation changes resulting fromClinical Trial Management experience with one business unit to another • Understand the benefits of a site-based approach Systems (CTMS) to CTMS • Benchmark against other industry professionals with peer-to-peer networking Adoption, Integration and Management Solutions PlUS! Choose from Two Pre-Conference to Maximize the Value of Investments Workshops — Thursday, March 24, 2011 A. Increase ROI B. Build Organizational through an Bridges for Cross-Functional March 24-25, 2011 • crowne Plaza Effective CTMS Collaboration and philaDelphia, pa Training Program Decision-Making The Next Best Thing to Being There… CBI PRSRT STD 600 Unicorn Park Drive • Woburn, MA 01801 U.S. PostageOrder the Online Compendium if you would like to capture what you’ve missed PAIDat the conference. It couldn’t be easier. The link to the online compendium is Galleryavailable for only $198 and includes the conference agenda, presentations and speakers’ biographies. Don’t miss out on this valuable information presented by industry leaders exclusively at this event. Simply fill out the order form and submit via phone, fax or website and you’ll receive the link to the Online Compendium within 2 weeks after the conference.• Registration Fee: Standard Advantage Pricing Conference & Workshop $2,095 $1,795 Conference only $1,795 $1,495 Advantage Pricing — Register by January 21, 2011, 2010 and SAVE $300. Fee includes continental breakfast, lunch, wine and cheese reception, refreshments and Online Compendium. Please make checks (in U.S. funds drawn on a U.S. bank) registration Card DO NOT REMOVE MAILING LABEL. PLEASE RETURN ENTIRE FORM. PC11134 payable to CBI Research, Inc. (No personal checks accepted) Advantage Pricing may not be combined with other discount offers, special category rates or promotions. Yes! Please register me for CBI’s 4th Annual Forum on Clinical Trial Management Systems (CTMS). Discounts only apply to standard rates.• Team Discount: Conference & Workshop A Conference & Workshop B Conference only Your organization may send 1 executive free for every 3 delegates registered. I am registering for ADVANTAGE PRICING We would like to take advantage of the TEAM DISCOUNT (see left for details). All registrations must be made at the same time to qualify.• Accommodations: Yes! Please send me the link to the Online Compendium. I am unable to attend the conference. To receive CBI’s special discounted hotel rate on line or by phone, please go to: Register 3 • On-line: www.cbinet.com/CTMS Do you have any special needs? ________________________________________________ Get 1 FREE • Phone reservations: 888.233.9527 and mention CBI’s CTMS Conference. KEY CODE (appears above mailing address): ___________________________________ Cut-off date is March 9, 2011. Reservations made after the cut-off date or after group room block has been filled (whichever comes first) will be accepted 1. NAME POSITION on a space and rate availability basis. Rooms are limited so please book early. All travel arrangements are subject to availability. 2. NAME POSITION• Venue: 3. NAME POSITION Crowne Plaza 1800 Market Street • Philadelphia, PA 19103 4. NAME POSITION Hotel reservations: 888.233.9527 Free Hotel direct line: 215.561.7500 COMPANY DIVISION• Substitution & Cancellation: ADDRESS Your registration may be transferred to a member of your organization up to 24 hours in advance of the conference. Cancellations received in writing on or before 14 days CITY STATE/COUNTRY ZIP/POSTAL CODE prior to the start date of the event will be refunded, less a $195 administrative charge. No refunds will be made after this date; however, the registration fee less the $195 TELEPHONE FAx E-MAIL administrative charge can be credited to another CBI conference if you register within 30 days from the date of this conference to an alternative CBI conference scheduled AUTHORIZED SIGNATURE within the next six months. In case of conference cancellation, CBI’s liability is limited to refund of the conference registration fee only. CBI reserves the right to alter this program Payment Options: Payment in full is required to process registration. Please call with any payment questions. without prior notice. Please Note: Speakers and agenda are subject to change. In the event of a speaker cancellation, every effort to find a suitable replacement will be made Enclosed is a check for payment in full (No personal checks accepted) Please without notice. The opinions of the conference faculty do not necessarily reflect those of photocopy the companies they represent or The Center for Business Intelligence. MC/Visa: this form for additional• Satisfaction Guaranteed: Amex: delegates. CBI stands behind the quality of its conferences. If you are not satisfied with the quality of the conference, a credit will be awarded towards a comparable NAME (AS APPEARS ON CARD) ExP. DATE CBI conference of your choice. Please contact 800-817-8601 for further information. CARDHOLDER SIGNATURE Advanced preparation for CBI conferences is not required. WeBSiTe Phone fAX e-MAil MAil 5 Easy Ways www.cbinet.com/ CTMS 800-817-8601 781-939-2490 cbireg@cbinet.com CBI Registration Dept. 339-298-2100 Please include all information 600 Unicorn Park Drive to REgistER outside the U.S. requested on registration card. Woburn, MA 01801